These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31613032)

  • 1. Zoledronic acid associated orbital inflammation.
    Han LS; Weatherhead RG
    Clin Exp Ophthalmol; 2020 Mar; 48(2):249-250. PubMed ID: 31613032
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate-induced orbital inflammation: more common than once thought?
    Chehade LK; Curragh D; Selva D
    Osteoporos Int; 2019 May; 30(5):1117-1120. PubMed ID: 30675627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.
    Procianoy F; Procianoy E
    Osteoporos Int; 2010 Jun; 21(6):1057-8. PubMed ID: 19859646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma.
    Tan M; Kalin-Hajdu E; Narayan R; Wong SW; Martin TG
    J Oncol Pharm Pract; 2019 Jul; 25(5):1253-1257. PubMed ID: 30005587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital Inflammation Secondary to Zoledronic Acid, a Rare Presentation.
    Muruganandam M; Sandhu H
    J Clin Rheumatol; 2016 Oct; 22(7):384. PubMed ID: 27488454
    [No Abstract]   [Full Text] [Related]  

  • 6. Orbital inflammatory disease in a patient treated with zoledronate.
    Kaur H; Uy C; Kelly J; Moses AM
    Endocr Pract; 2011; 17(4):e101-3. PubMed ID: 21803720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
    Herrera I; Kam Y; Whittaker TJ; Champion M; Ajlan RS
    BMC Ophthalmol; 2019 Feb; 19(1):51. PubMed ID: 30764790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
    Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
    Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
    Böni C; Kordic H; Chaloupka K
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma.
    Missotten G; Verheezen Y
    Bull Soc Belge Ophtalmol; 2010; (315):23-4. PubMed ID: 21110506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid-induced orbital inflammation.
    Khalid MF; Micieli J
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34413050
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
    Umunakwe OC; Herren D; Kim SJ; Kohanim S
    Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomatous Inflammation Induced by Bee Sting.
    Park HS; Lee JH
    JAMA Ophthalmol; 2016 Aug; 134(8):e161024. PubMed ID: 27548296
    [No Abstract]   [Full Text] [Related]  

  • 14. Sight-threatening acute orbital swelling from peribulbar local anesthesia.
    Walters G; Georgiou T; Hayward JM
    J Cataract Refract Surg; 1999 Mar; 25(3):444-6. PubMed ID: 10079454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of drug-induced orbital inflammatory disease.
    Ortiz-Perez S; Fernandez E; Molina JJ; Sanchez-Dalmau B; Navarro M; Corretger X; Olver JM
    Orbit; 2011 Jan; 30(1):37-9. PubMed ID: 21281079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronidase allergy after peribulbar anesthesia with orbital inflammation.
    Patil B; Agius-Fernandez A; Worstmann T
    J Cataract Refract Surg; 2005 Aug; 31(8):1480-1. PubMed ID: 16129269
    [No Abstract]   [Full Text] [Related]  

  • 17. Zoledronic acid is effective and safe in migratory osteoporosis.
    Evangelatos G; Fragoulis GE; Zampeli E; Kechagia M; Iliopoulos A
    Rheumatology (Oxford); 2020 Feb; 59(2):439-440. PubMed ID: 31411329
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
    Zhou W; Liu Y; Guo X; Yang H; Xu Y; Geng D
    Osteoporos Int; 2019 Aug; 30(8):1581-1589. PubMed ID: 31115592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral optic perineuritis due to nonspecific orbital inflammation: A case report.
    Nalcacioglu P; Acaroglu G
    Orbit; 2017 Dec; 36(6):452-455. PubMed ID: 28812938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
    Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
    Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.